Phase II study of capecitabine and cisplatin combination as first-line chemotherapy in Chinese patients with metastatic nasopharyngeal carcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/18172651

Download in:

View as

General Info

PMID
18172651